Genesis Research & Development Corporation Limited
(GEN) is a New Zealand-based biotechnology company. It has
built a broad therapeutic development platform targeting
immune disorders and cancer and is focusing on developing a
novel single stranded gene silencing technology using the
RNAi mechanism.